Compare Harley-Davidson Inc (HOG) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Harley-Davidson Inc vs GeneDx Holdings Corp — how do they compare? Harley-Davidson Inc trades at $25.99 (market cap $2.78B), while GeneDx Holdings Corp trades at $81.95 (market cap $2.44B). The key difference: Harley-Davidson Inc and GeneDx Holdings Corp are close in size by market cap, and Harley-Davidson Inc pays a 2.75% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.
| HOG | WGS | |
|---|---|---|
Market Cap | $2.78B | $2.44B |
Sector | Consumer Cyclical | Technology |
52-Week High | $31.03 | $167.51 |
52-Week Low | $17.19 | $34.51 |
Enterprise Value | $3.19B | $2.48B |
Dividend Yield | 2.75% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Harley-Davidson (HOG) trades at $25.95, down 0.57% with a bullish technical signal. The company reported Q2 2026 EPS of $0.75 beating estimates of $0.645, though revenue declined to $4.47B in 2025 from $5.8B in 2022. Valuation metrics appear reasonable with P/E of 14.84 and P/S of 0.72. Recent news highlights production returning to US facilities and raised 2026 guidance following stronger North American sales.
The outlook remains cautiously optimistic with analyst consensus at $26.00 target. Key opportunities include cost-cutting initiatives and domestic production advantages, while risks involve ongoing revenue pressure, competitive threats from Indian Motorcycle, and margin compression from rising raw material costs evident in recent quarterly results.
GeneDx Holdings Corp (WGS) trades at $82.07, up 5.38% in the past 24 hours, with technical indicators showing a bullish trend. The stock beat Q2 2026 EPS estimates but reported negative net income margins. Recent news highlights product expansion and institutional buying interest, though class-action lawsuits pose near-term sentiment risks.
Outlook is mixed: strong analyst buy ratings (90.9%) and a $79.25 consensus target suggest upside, but high valuation multiples and persistent losses require caution. Key risks include profitability challenges and legal overhangs, while revenue growth and market positioning offer long-term potential.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Harley-Davidson Inc
Harley-Davidson is a global leading manufacturer of heavyweight motorcycles, merchandise, parts, and accessories. It sells custom, cruiser, and touring motorcycles and offers a complete line of Harley-Davidson motorcycle parts, accessories, riding gear, and apparel, as well as merchandise. Harley-Davidson Financial Services provides wholesale financing to dealers and retail financing and insurance brokerage services to customers. Harley has historically captured about half of all heavyweight domestic retail motorcycle registrations, a metric it had ceded in 2020 as it repositioned the business, but a level it is working back toward. In recent years the firm has expanded into the adventure touring market with its Pan America model and into electric with the LiveWire brand.
Read more on HOG →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
